{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/6660f2b9aa134f00128d8e97?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Thursday, June 6, 2024","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1717629553527-c0cd900da8007404fbd9727cd7981c7a.jpeg?height=200","description":"<p>An FDA advisory panel recommended against using ecstasy as a treatment for PTSD. A Congressional subcommittee weighs reforming the 340B Drug Pricing Program.&nbsp;And a new study reports that drug shortages are more frequent and last longer. That’s coming up on today’s episode of Gist Healthcare Daily.&nbsp;</p>","author_name":"Gist Healthcare Daily"}